BeiGene Newsroom

BeiGene (688235): ODAC updates PD-1 treatment ESCC+G/GEJ voting progress

China International Capital CorporationOct 9 07:36

Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Maintains Target Price $284

Futu NewsSep 30 20:31

BeiGene Analyst Ratings

BenzingaSep 18 17:42

JMP Securities Initiates BeiGene(BGNE.US) With Buy Rating, Announces Target Price $288

Futu NewsSep 18 13:32

BofA Securities Maintains BeiGene(BGNE.US) With Hold Rating, Maintains Target Price $198

Futu NewsSep 10 20:31

Hold Rating on BeiGene Amid Mixed Sales Performance and Competitive Pressures

TipRanksSep 10 19:44

BeiGene (688235): Active expansion of overseas markets can be expected

Aug 30 16:57

Morgan Stanley Maintains BeiGene(BGNE.US) With Buy Rating, Cuts Target Price to $307

Futu NewsAug 26 21:31

Morgan Stanley Maintains BeiGene(BGNE.US) With Buy Rating, Cuts Target Price to $307

Futu NewsAug 24 22:31

BeiGene Analyst Ratings

BenzingaAug 20 22:14

JP Morgan Maintains Overweight on BeiGene, Raises Price Target to $200

BenzingaAug 20 22:14

J.P. Morgan Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $200

Futu NewsAug 20 20:33

TD Cowen Initiates BeiGene(BGNE.US) With Buy Rating, Announces Target Price $254

Futu NewsAug 19 19:32

TD Cowen Sticks to Its Buy Rating for BeiGene (BGNE)

TipRanksAug 19 19:01

Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $284

Futu NewsAug 16 21:32

Jefferies Maintains BeiGene(BGNE.US) With Buy Rating, Raises Target Price to $284

Futu NewsAug 16 20:32

Jefferies Sticks to Their Buy Rating for BeiGene (BGNE)

TipRanksAug 16 20:08

BeiGene (688235): The company's performance in 2024Q2 exceeded expectations and achieved profit from non-GAAP operating profits

Aug 16 07:16

BofA Securities Maintains BeiGene(BGNE.US) With Hold Rating, Raises Target Price to $198

Futu NewsAug 13 22:32

Hold Rating on BeiGene Amid Mixed Drug Performance and Strong Pipeline Potential

TipRanksAug 13 22:21